Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Biomarkers, Tumor | 5 | 2019 | 1314 | 0.76 | Why? |
| Urine | 1 | 2019 | 469 | 0.64 | Why? |
| NF-E2-Related Factor 1 | 1 | 2014 | 3 | 0.59 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.58 | Why? |
| Orthomyxoviridae | 2 | 2020 | 1168 | 0.57 | Why? |
| Japan | 9 | 2021 | 6653 | 0.55 | Why? |
| Sequence Analysis, DNA | 2 | 2019 | 2830 | 0.51 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2020 | 13720 | 0.51 | Why? |
| Urinary Bladder Neoplasms | 1 | 2019 | 614 | 0.48 | Why? |
| Mutation | 7 | 2021 | 12376 | 0.42 | Why? |
| Decontamination | 1 | 2020 | 1196 | 0.42 | Why? |
| Clinical Laboratory Techniques | 4 | 2020 | 23402 | 0.41 | Why? |
| DNA, Neoplasm | 2 | 2018 | 56 | 0.35 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.33 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.32 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2021 | 11367 | 0.28 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.26 | Why? |
| Lung Neoplasms | 5 | 2018 | 3228 | 0.25 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.24 | Why? |
| Multiplex Polymerase Chain Reaction | 2 | 2020 | 1439 | 0.23 | Why? |
| Adenocarcinoma | 2 | 2018 | 651 | 0.21 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.21 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.20 | Why? |
| Blood Glucose | 1 | 2014 | 3642 | 0.20 | Why? |
| Cystadenocarcinoma, Serous | 1 | 2018 | 18 | 0.19 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.19 | Why? |
| Phthalazines | 1 | 2018 | 26 | 0.19 | Why? |
| Liquid Biopsy | 1 | 2019 | 114 | 0.19 | Why? |
| Tissue Fixation | 1 | 2018 | 85 | 0.19 | Why? |
| Paraffin Embedding | 1 | 2018 | 105 | 0.18 | Why? |
| Formaldehyde | 1 | 2018 | 135 | 0.18 | Why? |
| Pyrophosphatases | 1 | 2018 | 39 | 0.18 | Why? |
| Immunoenzyme Techniques | 1 | 2020 | 448 | 0.18 | Why? |
| Peritoneal Neoplasms | 1 | 2018 | 110 | 0.17 | Why? |
| Circulating Tumor DNA | 1 | 2017 | 46 | 0.17 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.17 | Why? |
| Genes, p53 | 1 | 2017 | 20 | 0.17 | Why? |
| Metapneumovirus | 1 | 2020 | 465 | 0.17 | Why? |
| BRCA2 Protein | 1 | 2017 | 82 | 0.17 | Why? |
| BRCA1 Protein | 1 | 2017 | 102 | 0.17 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.16 | Why? |
| Meningeal Neoplasms | 1 | 2017 | 48 | 0.16 | Why? |
| Frameshift Mutation | 1 | 2017 | 158 | 0.16 | Why? |
| Small Cell Lung Carcinoma | 1 | 2018 | 133 | 0.16 | Why? |
| Neoplasms, Multiple Primary | 1 | 2017 | 61 | 0.16 | Why? |
| Leukopenia | 1 | 2018 | 280 | 0.15 | Why? |
| DNA Primers | 1 | 2020 | 1170 | 0.15 | Why? |
| Alphacoronavirus | 1 | 2020 | 392 | 0.15 | Why? |
| Piperazines | 1 | 2018 | 445 | 0.15 | Why? |
| MafG Transcription Factor | 1 | 2014 | 1 | 0.15 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.15 | Why? |
| Ships | 2 | 2021 | 1046 | 0.14 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.14 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.14 | Why? |
| Nasal Cavity | 1 | 2020 | 909 | 0.14 | Why? |
| Diagnostic Errors | 1 | 2021 | 865 | 0.14 | Why? |
| Rhinovirus | 1 | 2020 | 979 | 0.13 | Why? |
| Dietary Fats | 1 | 2014 | 96 | 0.13 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.13 | Why? |
| Carcinoma | 1 | 2017 | 256 | 0.13 | Why? |
| Sarcoma | 1 | 2017 | 290 | 0.13 | Why? |
| Repressor Proteins | 1 | 2014 | 232 | 0.12 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.12 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2014 | 192 | 0.12 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.12 | Why? |
| Hepatitis B, Chronic | 1 | 2019 | 616 | 0.12 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.11 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.11 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.11 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.10 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.10 | Why? |
| Humans | 23 | 2021 | 930598 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2017 | 830 | 0.10 | Why? |
| Species Specificity | 1 | 2014 | 1356 | 0.10 | Why? |
| Neoplasm Staging | 4 | 2018 | 1999 | 0.10 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.10 | Why? |
| Breast Neoplasms | 2 | 2017 | 3633 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2019 | 1222 | 0.09 | Why? |
| Crohn Disease | 1 | 2018 | 959 | 0.09 | Why? |
| Insulin Resistance | 1 | 2014 | 669 | 0.09 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 896 | 0.09 | Why? |
| Colitis, Ulcerative | 1 | 2018 | 1037 | 0.09 | Why? |
| Body Weight | 1 | 2014 | 1074 | 0.09 | Why? |
| Transcription, Genetic | 1 | 2014 | 1326 | 0.09 | Why? |
| Hepatitis C | 1 | 2019 | 1514 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2019 | 1956 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2019 | 1810 | 0.08 | Why? |
| Mice, Transgenic | 1 | 2014 | 2739 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2019 | 1666 | 0.08 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.07 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.07 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.07 | Why? |
| Mice, Inbred C57BL | 1 | 2014 | 5542 | 0.06 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.06 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.05 | Why? |
| Liver | 1 | 2014 | 4007 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.05 | Why? |
| Carboplatin | 1 | 2018 | 76 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Aged | 6 | 2021 | 215776 | 0.04 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
| Clone Cells | 1 | 2018 | 312 | 0.04 | Why? |
| Mercaptopurine | 1 | 2018 | 68 | 0.04 | Why? |
| Etoposide | 1 | 2018 | 115 | 0.04 | Why? |
| Exons | 1 | 2018 | 158 | 0.04 | Why? |
| Breast Neoplasms, Male | 1 | 2017 | 48 | 0.04 | Why? |
| Germ-Line Mutation | 1 | 2017 | 86 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.04 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 1573 | 0.04 | Why? |
| Heterozygote | 1 | 2018 | 249 | 0.04 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.04 | Why? |
| Paclitaxel | 1 | 2017 | 124 | 0.04 | Why? |
| Erythrocyte Indices | 1 | 2018 | 207 | 0.04 | Why? |
| Radiotherapy, Adjuvant | 1 | 2017 | 180 | 0.04 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.04 | Why? |
| Male | 8 | 2021 | 367725 | 0.04 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.04 | Why? |
| Bevacizumab | 1 | 2017 | 149 | 0.04 | Why? |
| Gene Deletion | 1 | 2017 | 430 | 0.04 | Why? |
| Drug Substitution | 1 | 2018 | 385 | 0.04 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.03 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.03 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.03 | Why? |
| Remission Induction | 1 | 2018 | 950 | 0.03 | Why? |
| Prednisolone | 1 | 2018 | 443 | 0.03 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| Antibodies | 1 | 2021 | 846 | 0.03 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.03 | Why? |
| Obesity | 1 | 2014 | 7388 | 0.03 | Why? |
| Female | 9 | 2021 | 380317 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Gene Frequency | 1 | 2017 | 1210 | 0.03 | Why? |
| Methyltransferases | 1 | 2018 | 720 | 0.03 | Why? |
| Early Diagnosis | 1 | 2021 | 2443 | 0.03 | Why? |
| Africa | 1 | 2021 | 2986 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.03 | Why? |
| Adult | 4 | 2021 | 244371 | 0.03 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Leukocyte Count | 1 | 2018 | 3178 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Fatal Outcome | 1 | 2017 | 3438 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.02 | Why? |
| Animals | 1 | 2014 | 78931 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
Hirotsu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_